Awardee OrganizationMOUNT SINAI SCHOOL OF MEDICINE OF CUNY
Description
Abstract Text
This is a Phase III, randomized, double-blind, placebo-controlled, trial
of the safety, tolerability and efficacy of methionine for the treatment
of AIDS associated vacuolar myelopathy. The study will assess the
efficacy of methionine in improving the clinical manifestations of AIDS
myelopathy including lower extremity weakness, spasticity, clinical
disability and urinary function.
No Sub Projects information available for 3M01RR000071-35 0403
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3M01RR000071-35 0403
Patents
No Patents information available for 3M01RR000071-35 0403
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3M01RR000071-35 0403
Clinical Studies
No Clinical Studies information available for 3M01RR000071-35 0403
News and More
Related News Releases
No news release information available for 3M01RR000071-35 0403
History
No Historical information available for 3M01RR000071-35 0403
Similar Projects
No Similar Projects information available for 3M01RR000071-35 0403